Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Synthetic method of istradefylline

A synthetic method and the technology of istradefylline, which are applied in the field of medicine, can solve the problems of simultaneous methylation of dimethyl carbonate, low yield, and reduced yield, and achieve good reaction selection, high yield, and accelerated selective effect

Active Publication Date: 2020-08-18
LIANYUNGANG GUIKE PHARMA
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But obviously, there are competing reactions in the ring closing process, which will significantly reduce the yield. At the same time, it is difficult for the so-called dimethyl carbonate to be methylated at the same time under weakly alkaline conditions, resulting in a significantly lower yield.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] A synthetic method for istradefylline, comprising the following steps: (1) 1 mass part of compound 1 is dispersed in 5 mass parts of absolute ethanol, heated to 60°C, 1 mass part of anhydrous sodium carbonate is added, and 1.65 parts by mass of compound 2 was dissolved in 5 parts by mass of absolute ethanol, slowly added dropwise for 3 hours, and kept warm for 0.5 hours after the addition; Sodium solution, adjust pH=12, heat to 120°C in airtight, pressure 0.22Mpa, keep warm for 2 hours; (3) After cooling, at 0-5°C, slowly add dimethyl sulfate, compound 1 and dimethyl sulfate Molar ratio of ester = 1:1.05, stirring rapidly for 7 hours; (4) After filtering, heat to 60°C in methanol for beating, filter after cooling, and dry.

[0018] After liquid phase characterization, the final yield was 62.3%, and the purity was 99.7%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a synthetic method of istradefylline, and belongs to the technical field of medicines. The synthesis method of the istradefylline mainly comprises the steps of acylation, ringclosing, methylation and the like. The method is high in yield, simple in step and single in solvent, wherein reaction selectivity can be effectively promoted and side reactions are reduced; after ring closing is finished, dimethyl sulfate is dropwise added for a methylation reaction by means of the alkalinity of dimethyl sulfate. The method can be more thorough and cleaner than a dimethyl carbonate reaction in the prior art. The whole process can be carried out in one reaction kettle, wherein the solvent only relates to ethanol and subsequently refined methanol and can be recycled, so that the synthesis method has advantages of high reaction selectivity and yield.

Description

technical field [0001] The invention belongs to the technical field of medicine, in particular to a method for synthesizing istradefylline. Background technique [0002] Itradefylline (KW-6002) is an oral adenosine A2a receptor antagonist developed by Kyowa HakkoKirin, a non-dopamine compound, which improves the movement of Parkinson's patients by changing the activity of neurons function, can improve the initial dyskinesia of Parkinson's patients; at the same time, it has brought a turn for the treatment of late Parkinson's patients, and proved that it can affect other neurotransmitters, non-dopamine drugs can benefit late Parkinson's patients; Dopa-like products (L-DOPA) are used in combination for patients with Parkinson's disease to improve the symptoms of diminished efficacy, and can also reduce the dosage of levodopa, thereby preventing or delaying the occurrence of dyskinesia. In order to reduce or avoid the adverse reactions of istradefylline, many researchers at ho...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D473/06
CPCC07D473/06
Inventor 刘志卓长城李响薛旺迁刘子畅
Owner LIANYUNGANG GUIKE PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com